Coventry, UK, 30th September 2020 / Sciad Newswire / NanoSyrinx, an emerging biotechnology company developing new therapeutic modalities for Cell & Gene editing, announced the closing of a Pre-Seed financing led by M Ventures (Amsterdam, The Netherlands), the corporate venture capital arm of Merck. BioCity (Nottingham, United Kingdom) and...
XenoGesis has been acquired by leading drug discovery CRO, Sygnature Discovery, strengthening the combined DMPK offering and enhancing existing capabilities and expertise. This latest acquisition by Sygnature serves to meet the increasing demand for DMPK services and boosts the company’s reach into the pre-clinical space. XenoGesis’ novel...
BioCity, Nottingham based Sygnature Discovery, a world-leading integrated discovery and pre-clinical solutions provider, has appointed Dr Andy Mead as Director and Head of Drug Abuse and Substance Use Disorders at its integrated in vivo pharmacology company, RenaSci. With 25 years’ experience in the science of...
University of Dundee researchers hope to turn their spinout venture into a biotech company worth hundreds of millions of pounds by helping to treat people with eczema, rheumatoid arthritis and other inflammatory conditions. In4Derm Ltd is an innovative drug discovery company developing the next generation of...
Excerpt from “Life Sciences Innovation and Responding to COVID” ministerial report from Ivan McKee, minister for trade, investment and innovation. This report aims to provide a snapshot of just some of the innovation in the sector to support testing supply chains as well as vaccine development...
Nottingham experts who designed new eyesight-saving technology are to launch more products which could speed up treatment while reducing the impact on hospital waiting lists and patient visits following COVID-19 restrictions. NuVision which is based at MediCity, Nottingham, has developed the designs from human amniotic membrane...
BioCity Nottingham based AdamsonJones has raised over £2,500 for The Friary and Alzheimer’s Society in a charity challenge with a difference. The East Midlands-based firm of patent and trade mark attorneys has successfully completed a challenge to collectively walk/run/cycle 750.5 miles to make a virtual journey...
Opportunity North East (ONE) is launching a new programme to help translate life sciences research and ideas into growth businesses that positively impact healthcare delivery and patient outcomes. The programme of four 90-minute online workshops will help researchers, clinicians and potential entrepreneurs to start their commercialisation journeys. ONE...
Nottingham, UK based Footfalls & Heartbeats, a smart textiles developer has created a knitted shoe upper which can measure gait in a person whether walking or running. The sensor embedded shoe uppers are made on a Santoni X machine. Kiwi founder Simon McMaster commented on the...
BioCity, Nottingham contract research organisation has appointed a new managing director. Barbara McManus has joined HistologiX which forms part of the Intelligent Tissue Group (ITG) alongside Tissue Solutions Ltd. McManus joined Tissue Solutions Ltd as its UK Biosample Project Manager in 2018. She said: "I’m looking forward to...